Medical Properties Trust Future Growth
Future criteria checks 4/6
Medical Properties Trust is forecast to grow earnings and revenue by 112.3% and 9.1% per annum respectively. EPS is expected to grow by 117.3% per annum. Return on equity is forecast to be 2.2% in 3 years.
Key information
112.3%
Earnings growth rate
117.3%
EPS growth rate
Health Care REITs earnings growth | 22.8% |
Revenue growth rate | 9.1% |
Future return on equity | 2.2% |
Analyst coverage | Good |
Last updated | 14 Nov 2024 |
Recent future growth updates
Recent updates
Medical Properties Trust: Oversold And Undervalued Even Against Headwinds
Nov 24Medical Properties Trust: Investors Should Be Worried About Liquidity Issues Ahead
Nov 14Medical Properties Trust: Buy The Dip At A 50% Discount To Book Value
Nov 08Medical Properties Trust Q3 Preview: Rare Insider Buy Indicates Improving Sentiment
Oct 29Medical Properties Trust: Why Basket Making Is Important
Oct 21My Biggest Loser List (Part 1): Medical Properties Trust (Rating Downgrade)
Oct 12Medical Properties Trust Bulls Vs. 40%+ Short Interests
Sep 27Medical Properties Trust: The Path To Gains Is Clearer Than Ever
Sep 20Medical Properties Trust Soars On Positive Steward News
Sep 12Upgrading Medical Properties Trust On Possible Bullish Catalyst
Sep 06Medical Properties Trust: Weak Fundamentals And Bearish Technicals Vs. Low Valuations
Aug 27Medical Properties Trust: Cash Flow Concerns Persist
Aug 21Medical Properties Trust Is A Steal At This Price (Upgrade)
Aug 14Medical Properties Trust: Results Incoming
Aug 06Medical Properties Trust: The Endgame Unfolds
Jul 19Medical Properties Trust: Why I Think It Is Worth Having A Pop
Jul 03Medical Properties Trust: The Market Paints A Bright Future - Ignore
Jun 26Medical Properties Trust's Turnaround Is Here - Initiate Cautious Buy
Jun 16Medical Properties Trust: Steward Bankruptcy Exposes Shorts To Squeeze, 11.2% Dividend Yield
Jun 10Medical Properties Trust: Renewed Risks To The Dividend
Jun 02Medical Properties Trust Stock: Mr. Market Is Underestimating This REIT
May 25Medical Properties: Don't Worry About The Steward Bankruptcy
May 12Medical Properties Trust: Don't Celebrate Too Early
May 05Very Good News For Medical Properties Trust
Apr 25Medical Properties Trust: A Key Level Is Now In Sight (Technical Analysis)
Apr 18Medical Properties Trust: No High Rewards Without High Risks (Rating Upgrade)
Apr 11Medical Properties Trust Q4: Wouldn't Touch This REIT With A 10-Foot Pole
Apr 04Medical Properties Trust: Stock Price Is Not Going Anywhere
Mar 18Medical Properties Trust: Downgrading On Another Red Flag
Mar 07Medical Properties Trust: Don't Fall For This Bear Market Rally
Mar 01Medical Properties Trust Q4: No Guidance Causes Uncertainties
Feb 21Confessions Of A Medical Properties Trust Bagholder
Jan 29Lessons From Medical Properties Trust Stock's Implosion
Jan 16Medical Properties Trust: A Cautionary Tale On Reaching For Yield
Jan 08Medical Properties Trust: My Biggest Loser In 2023 (Rating Downgrade)
Jan 02Medical Properties Trust: Dead Money At Best, Better To Avoid
Dec 25Medical Properties Trust: Holding Through Recovery Efforts
Dec 18Medical Properties Trust: Pricey Valuation With Various Downside Risks
Dec 04Sell Medical Properties Trust And Buy These 10%-Yielding Blue Chips Instead
Nov 22Medical Properties Trust: Invest In 12% Yielding Debt Over Shares
Nov 13Medical Properties Trust: The Future Looks Bleak
Nov 02Medical Properties Trust Is Fighting For Its Life
Oct 26Is Medical Properties Trust A Potential Takeover Target?
Oct 20Medical Properties Trust: Why I Am Selling At The Lows And Downgrading To 'Strong Sell'
Oct 11Medical Properties Trust: Sifting Through The Rubble
Oct 01Medical Properties Trust: A Disaster Investors Should Have Seen Coming
Sep 17Medical Properties Trust: The Safest Dividend Is Probably The One That's Just Been Cut (Upgrade)
Aug 29Medical Properties Trust: The Bottom Is In
Aug 22Medical Properties Trust: Dividend Cut Incoming (Downgrade)
Aug 16Earnings and Revenue Growth Forecasts
Date | Revenue | Earnings | Free Cash Flow | Cash from Op | Avg. No. Analysts |
---|---|---|---|---|---|
12/31/2026 | 988 | 104 | N/A | N/A | 6 |
12/31/2025 | 973 | 115 | N/A | N/A | 6 |
12/31/2024 | 995 | -1,836 | N/A | N/A | 2 |
9/30/2024 | 660 | -2,663 | 304 | 304 | N/A |
6/30/2024 | 731 | -1,745 | 403 | 403 | N/A |
3/31/2024 | 805 | -1,466 | 444 | 444 | N/A |
12/31/2023 | 886 | -558 | 506 | 506 | N/A |
9/30/2023 | 1,417 | -35 | 551 | 551 | N/A |
6/30/2023 | 1,463 | 70 | 607 | 607 | N/A |
3/31/2023 | 1,528 | 302 | 695 | 695 | N/A |
12/31/2022 | 1,584 | 901 | 739 | 739 | N/A |
9/30/2022 | 1,612 | 1,247 | 792 | 792 | N/A |
6/30/2022 | 1,646 | 1,197 | 790 | 790 | N/A |
3/31/2022 | 1,620 | 1,122 | 802 | 802 | N/A |
12/31/2021 | 1,573 | 654 | 812 | 812 | N/A |
9/30/2021 | 1,496 | 558 | 753 | 753 | N/A |
6/30/2021 | 1,433 | 517 | 694 | 694 | N/A |
3/31/2021 | 1,341 | 512 | 699 | 699 | N/A |
12/31/2020 | 1,270 | 429 | 618 | 618 | N/A |
9/30/2020 | 1,192 | 449 | 609 | 609 | N/A |
6/30/2020 | 1,084 | 408 | 585 | 585 | N/A |
3/31/2020 | 984 | 378 | 514 | 514 | N/A |
12/31/2019 | 870 | 372 | 494 | 494 | N/A |
9/30/2019 | 794 | 319 | 477 | 477 | N/A |
6/30/2019 | 765 | 966 | 451 | 451 | N/A |
3/31/2019 | 775 | 998 | 441 | 441 | N/A |
12/31/2018 | 799 | 1,013 | 449 | 449 | N/A |
9/30/2018 | 819 | 1,008 | 441 | 441 | N/A |
6/30/2018 | 796 | 349 | N/A | 404 | N/A |
3/31/2018 | 757 | 311 | N/A | 393 | N/A |
12/31/2017 | 715 | 288 | N/A | 362 | N/A |
9/30/2017 | 655 | 260 | N/A | 316 | N/A |
6/30/2017 | 606 | 254 | N/A | 282 | N/A |
3/31/2017 | 566 | 235 | N/A | 260 | N/A |
12/31/2016 | 541 | 224 | N/A | 264 | N/A |
9/30/2016 | 517 | 240 | N/A | 243 | N/A |
6/30/2016 | 505 | 192 | N/A | 257 | N/A |
3/31/2016 | 479 | 161 | N/A | 234 | N/A |
12/31/2015 | 445 | 139 | N/A | 207 | N/A |
9/30/2015 | 395 | 95 | N/A | 187 | N/A |
6/30/2015 | 362 | 101 | N/A | 188 | N/A |
3/31/2015 | 338 | 78 | N/A | 174 | N/A |
12/31/2014 | 315 | 50 | N/A | 150 | N/A |
9/30/2014 | 301 | 48 | N/A | 135 | N/A |
6/30/2014 | 280 | 45 | N/A | 135 | N/A |
3/31/2014 | 261 | 70 | N/A | 132 | N/A |
12/31/2013 | 246 | 88 | N/A | 141 | N/A |
Analyst Future Growth Forecasts
Earnings vs Savings Rate: MPW is forecast to become profitable over the next 3 years, which is considered faster growth than the savings rate (2.6%).
Earnings vs Market: MPW is forecast to become profitable over the next 3 years, which is considered above average market growth.
High Growth Earnings: MPW is expected to become profitable in the next 3 years.
Revenue vs Market: MPW's revenue (9.1% per year) is forecast to grow faster than the US market (8.9% per year).
High Growth Revenue: MPW's revenue (9.1% per year) is forecast to grow slower than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: MPW's Return on Equity is forecast to be low in 3 years time (2.2%).